(Q48425293)

11 February 2018

meta-analysis

0 references

title

Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke (English)

1 reference

11 February 2018

author name string

Paciaroni M

1

1 reference

11 February 2018

Agnelli G

2

1 reference

11 February 2018

Caso V

3

1 reference

11 February 2018

Venti M

4

1 reference

11 February 2018

Alberti A

5

1 reference

11 February 2018

Milia P

6

1 reference

11 February 2018

Silvestrelli G

7

1 reference

11 February 2018

Biagini S

8

1 reference

11 February 2018

publication date

1 September 2006

1 reference

11 February 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

11 February 2018

volume

4

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

page(s)

1957-1961

1 reference

11 February 2018

The significance of prestroke aspirin dosage in fatal outcome of acute stroke

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Does platelet antiaggregant therapy lessen the severity of stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Does daily aspirin diminish severity of first-ever stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Neurovascular territory involved in different etiological subtypes of ischemic stroke in the Perugia Stroke Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

The Perugia hospital-based Stroke Registry: report of the 2nd year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

The clinical meaning of Rankin 'handicap' grades after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Platelet activity and stroke severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Aspirin resistance: definition, mechanisms and clinical read-outs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

Strengthening acute stroke trials through optimal use of disability end points

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02095.X

10.1111/J.1538-7836.2006.02095.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018